blonanserin has been researched along with Cognition Disorders in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, L; Liao, M; Liu, B; Xu, S; Zhang, Y; Zheng, Q | 1 |
| Enomoto, T; Ikeda, K; Ikejiri, M; Iwamura, Y; Kiyoshi, A; Kotani, M; Matsumoto, A; Matsumoto, K; Murai, T; Nakako, T; Nakayama, T; Ogi, Y | 1 |
| Ishibashi, T; Nakamura, H; Nishikawa, H; Une, T | 1 |
| Anai, K; Arai, J; Funamoto, Y; Ito, Y; Kaneda, Y; Kitajima, R; Miyake, N; Miyamoto, S; Ogino, S; Ojima, K; Sumiyoshi, T; Tadokoro, M; Tenjin, T; Teramoto, H; Tsukahara, S; Yamaguchi, N | 1 |
2 review(s) available for blonanserin and Cognition Disorders
| Article | Year |
|---|---|
[Research progress in mechanisms and clinical application for blonanserin and lurasidone in improving cognitive function of schizophrenia].
Topics: Antipsychotic Agents; Cognition Disorders; Humans; Lurasidone Hydrochloride; Piperazines; Piperidines; Schizophrenia; Schizophrenic Psychology | 2017 |
[Pharmacological profiles and clinical effects of blonanserin (Lonasen) on schizophrenia].
Topics: Animals; Antidepressive Agents, Second-Generation; Cognition Disorders; Dopamine D2 Receptor Antagonists; Double-Blind Method; Drug Discovery; Drug-Related Side Effects and Adverse Reactions; Humans; Piperazines; Piperidines; Randomized Controlled Trials as Topic; Schizophrenia; Serotonin 5-HT2 Receptor Antagonists; Treatment Outcome | 2008 |
1 trial(s) available for blonanserin and Cognition Disorders
| Article | Year |
|---|---|
Effect of blonanserin on cognitive function in antipsychotic-naïve first-episode schizophrenia.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Chronic Disease; Cognition Disorders; Female; Humans; Male; Piperazines; Piperidines; Prospective Studies; Psychiatric Status Rating Scales; Quality of Life; Schizophrenia; Severity of Illness Index; Single-Blind Method; Treatment Outcome; Young Adult | 2012 |
1 other study(ies) available for blonanserin and Cognition Disorders
| Article | Year |
|---|---|
The atypical antipsychotic blonanserin reverses (+)-PD-128907- and ketamine-induced deficit in executive function in common marmosets.
Topics: Animals; Antipsychotic Agents; Benzopyrans; Callithrix; Cognition Disorders; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Executive Function; Female; Ketamine; Male; Mental Recall; Oxazines; Piperazines; Piperidines | 2016 |